Endoscopy 2005; 37(3): 213-216
DOI: 10.1055/s-2005-860994
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Long-Term Failure of Endoscopic Suturing in the Treatment of Gastroesophageal Reflux: A Prospective Follow-Up Study

H.  Abou-Rebyeh[*] 1 , N.  Hoepffner[*] 2 , T.  Rösch 1 , E.  Osmanoglou 1 , J.  H.  Haneke 1 , R.  E.  Hintze 1 , B.  Wiedenmann 1 , H.  Mönnikes 1
  • 1Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum, Humboldt University, Berlin, Germany
  • 2Department Medizinische Klinik II, Universitätskliniken Johann-Wolfgang-Goethe Universität, Frankfurt am Main, Germany
Further Information

Publication History

Submitted 12 November 2004

Accepted after Revision 12 November 2004

Publication Date:
24 February 2005 (online)

Background and Study Aims: Several endoscopic antireflux therapies have been marketed, but long-term data on their objective and clinical efficacy are sparse. This report presents prospective 1-year follow-up results, including technical, clinical, and functional success rates, for the first of these treatments to be developed, endoscopic gastroplication (EGP).Patients and Methods: A total of 43 EGP procedures were carried out in 38 patients with gastroesophageal reflux disease (GERD). Two or three EndoCinch gastroplications were constructed at the level of the gastric cardia in each patient; five patients were treated twice within 6 - 12 months. Each endoscopic suture joined two gastric folds to each other as a double fold, known as a ”gastroplication”, in order to narrow the esophagogastric junction. Postprocedure data after 2 months and after 1 year were compared with preoperative data, focusing on symptoms, medication requirements, endoscopic findings, and pH-metry results.Results: In contrast to the findings at 2 months (which showed that 72 % of the sutures were present and that there was a reduction in the percentage of time when the esophageal pH was < 4 from 15.4 % to 8.7 %), the results 1 year after EGP were considered to indicate failure of the treatment in all 38 patients because none of them still had all of the initially placed gastroplications in situ (90 % of gastroplications were lost). The percentage of patients who did not require proton pump inhibitor medication decreased from 52 % at 2 months to only 20 % at 1 year and even more patients had evidence of reflux esophagitis at 1 year (56 %) than had initially demonstrated signs of this (41 %).Conclusions: EGP has some short-term beneficial effects on clinical symptoms and pH-metry. However, mainly due to the loss of the endoscopically placed sutures, these effects were not maintained at the 1-year follow-up. EGP cannot therefore be recommended for routine clinical use. Better endoscopic methods need to be developed, and they should be adequately tested before being marketed.


  • 1 Galmiche J P, Bruley des Varannes S. Endoluminal therapies for gastro-oesophageal reflux disease.  Lancet. 2003;  361 1119-1121
  • 2 Triadafilopoulos G, DiBaise J K, Nostrant T T. et al . The Stretta procedure for the treatment of GERD: 6- and 12-month follow-up of the US open label trial.  Gastrointest Endosc. 2002;  55 149-156
  • 3 Johnson D A, Ganz R, Aisenberg J. et al . Endoscopic, deep mural implantation of Enteryx for the treatment of GERD: 6-month follow-up of a multicenter trial.  Am J Gastroenterol. 2003;  98 250-258
  • 4 Fockens P, Bruno M J, Gabbrielli A. et al . Endoscopic augmentation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease: a multicenter study of the gatekeeper reflux repair system.  Endoscopy. 2004;  36 682-689
  • 5 Filipi C J, Lehman G A, Rothstein R I. et al . Transoral, flexible endoscopic suturing for treatment of GERD: a multicenter trial.  Gastrointest Endosc. 2001;  53 416-422
  • 6 Corley D A, Katz P, Wo J M. et al . Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial.  Gastroenterology. 2003;  125 668-676
  • 7 Swain P, Park P O, Mills T. Bard EndoCinch: the device, the technique, and pre-clinical studies.  Gastrointest Endosc Clin N Am. 2003;  13 75-88
  • 8 Mahmood Z, McMahon B P, Arfin Q. et al . EndoCinch therapy for gastro-oesophageal reflux disease: a 1-year prospective follow-up.  Gut. 2003;  52 34-39
  • 9 Velanovich V, Ben-Menachem T, Goel S. Case-control comparison of endoscopic gastroplication with laparoscopic fundoplication in the management of gastroesophageal reflux disease: early symptomatic outcomes.  Surg Laparosc Endosc Percutan Tech. 2002;  12 219-223
  • 10 Chadalavada R, Lin E, Swafford V. et al . Comparative results of endoluminal gastroplasty and laparoscopic antireflux surgery for the treatment of GERD.  Surg Endosc. 2004;  18 261-265
  • 11 Feitoza A B, Gostout C J, Rajan E. et al . Understanding endoluminal gastroplications: a histopathologic analysis of intraluminal suture plications.  Gastrointest Endosc. 2003;  57 868-876
  • 12 Dai Q, Brasseur J G, Dimitriou J. et al . 2-D and 3-D endoluminal ultrasound localization of endoscopic plications with simultaneous manometry (location of plications and depth of sutures) [abstract].  Gastroenterology. 2004;  126 AB496
  • 13 Ponchon T, Boyer J, Grimaud J C. et al . A prospective multicenter phase II study to evaluate the EndoCinch suturing system for the treatment of GERD [abstract].  Gastrointest Endosc. 2004;  59 AB244
  • 14 Zabel-Langhennig A, Schiefke I, Neumann S. et al . Endoscopic gastroplication (EndoCinch) as an alternative option in treatment of GERD: an 18-month follow-up [abstract].  Gastroenterology. 2004;  126 AB330
  • 15 Schilling D, Kiesslich R, Galle P R, Riemann J F. First experience with a new endoscopic suture device (ESD) for endoscopic, endoluminal therapy of GERD [abstract].  Gastrointest Endosc. 2004;  59 AB246

1 contributed equally

H. Abou-Rebyeh, M. D.

Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin

Campus Virchow-Klinikum · Humboldt University · Augustenburger Platz 1 · 13353 Berlin · Germany

Fax: +49-30-450-553-917

Email: hassan.abou-rebyeh@charite.de